![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2006, European Molecular Biology Organization Yeast homolog of a cancer-testis antigen defines a new transcription complex 1Centre National de la Recherche Scientifique, Centre de Genetique Moleculaire, Gif sur Yvette, Paris, France 2Institut Pasteur, Génopole, Plate-Forme de Protéomique, Paris Cedex, France 3Miltenji Biotech GmbH, Koeln, Germany 4Biochemistry Department, F Edward Hébert School of Medicine, USUHS, Bethesda, MD, USA aCentre National de la Recherche Scientifique, Centre de Genetique Moleculaire, 91190 Gif sur Yvette, Paris, France. Tel.: +33 1 69823809; Fax: +33 1 69823877; E-mail: libri/at/cgm.cnrs-gif.fr *Present address: Department of Biochemistry, Oxford University, South Parks Road, Oxford OX1 3QU, UK †Present address: Institut de Génétique et Microbiologie, Université Paris-Sud, 91405 Orsay, France Received December 13, 2005; Accepted June 20, 2006. This article has been cited by other articles in PMC.Abstract We have isolated a new yeast gene (PCC1) that codes for a factor homologous to human cancer-testis antigens. We provide evidence that Pcc1p is a new transcription factor and that its mutation affects expression of several genes, some of which are involved in cell cycle progression and polarized growth. Mutation of Pcc1p also affects the expression of GAL genes by impairing the recruitment of the SAGA and Mediator co-activators. We characterize a new complex that contains Pcc1p, a kinase, Bud32p, a putative endopeptidase, Kae1p and two additional proteins encoded by ORFs YJL184w and YMLO36w. Genetic and physical interactions among these proteins strongly suggest that this complex is a functional unit. Chromatin immunoprecipitation experiments and multiple genetic interactions of pcc1 mutants with mutants of the transcription apparatus and chromatin modifying enzymes underscore the direct role of the complex in transcription. Functional complementation experiments indicate that the transcriptional function of this set of genes is conserved throughout evolution. Keywords: cancer-testis antigens, EKC-KEOPS, endopeptidase-ATPase, kinase, transcription Introduction Transcription of approximately 10% of the yeast genome occurs in a cell-cycle-dependent manner (Spellman et al, 1998). For almost half of these genes, the peak of transcription takes place around START (Spellman et al, 1998; Horak et al, 2002) when cells enter a new cycle and start budding. Thus, it is not surprising that an efficient transcriptional machinery is required for the passage through START. Indeed, mutation of several factors of the transcriptional apparatus leads to defects in START and the accumulation of unbudded cells (Jahng et al, 1988; Prendergast et al, 1990; Drebot et al, 1993; Walker et al, 1997; Koch et al, 1999). Modulation of gene expression is also critical for yeast conjugation. The response to mating pheromone in Saccharomyces cerevisiae involves the transcriptional activation of roughly 200 genes (Roberts et al, 2000), which ultimately determines cell-cycle arrest in the G1 phase and the formation of mating projections. Transcription starts when specific activators bind to their cognate sites on the DNA and recruit co-activator complexes. Co-activators promote the formation of the preinitiation complex (PIC) containing general transcription factors (GTFs) and RNA polymerase II (RNAPII) at the core promoters. This event determines the initiation of transcription, which is followed by elongation and termination. Transcription through chromatin requires the action of chromatin modifying and chromatin remodeling factors. Covalent modifications of histones include phosphorylation, ubiquitylation, methylation and acetylation (Strahl and Allis, 2000; Jenuwein and Allis, 2001). Acetylation of histone N-terminal tails is generally associated with transcriptional activity and histone acetyltransferases (HAT) are recruited to promoters by transcriptional activators. Although several histone deacetylases (HDAC) contribute to transcriptional repression by interacting with specific DNA-binding repressors, recent reports suggest that in some instances it is the dynamic interplay between acetylation and deacetylation that affects transcriptional activity (Wang et al, 2002; De Nadal et al, 2004). Post-translational modification of transcription factors can also ultimately lead to their degradation (Muratani and Tansey, 2003; Gillette et al, 2004; Muratani et al, 2005) although the mechanism of proteolysis-mediated transcriptional control is still unclear. Here, we report the first functional characterization of new S. cerevisiae proteins involved in transcription. These proteins belong to a complex that we have named the EKC (Endopeptidase-like Kinase Chromatin-associated) complex. Mutation of EKC complex components leads to several defects in cell cycle progression and polarized growth that can be ascribed to a defective transcriptional response. We provide evidence that the EKC complex impacts transcription of GAL genes and is required for the efficient recruitment of transcriptional co-activators. Remarkably, the complex contains a protein kinase, Bud32p and a putative metalloprotease/ATPase, Kae1p. We show that the conserved zinc-binding domain of Kae1p is essential for its function, suggesting a proteolytic activity for the EKC complex that might be related to its role in transcription. Several subunits of the complex are conserved from archae to man and we provide evidence that these sequence similarities reflect a functional homology. Together, these data point to the existence of a new function in transcription that has deep evolutionary roots. Results Isolation of the PCC1 gene We performed a screen to isolate suppressors of a splicing defect due to a U to A mutation in the fifth nucleotide of the U1snRNP particle (U1-5A; Seraphin et al, 1988), which leads to a cold-sensitive phenotype. Four such suppressors contained genomic fragments overlapping an intergenic region between MLP1 and YKR096w. Close inspection of the region revealed the presence of a short putative ORF containing an intron with a noncanonical splice site (GUAaGU). While this work was in progress, a putative ORF was identified based on phylogenetic analysis and assigned the name YKR095-A (Brachat et al, 2003). A small protein of about 10 kDa derived from this ORF could be identified both by chromosomal tagging and mass spectrometry analysis (see below). We called this gene PCC1 (Polarized growth Chromatin-associated Controller 1, see below). Overexpression of PCC1 on a multicopy plasmid, or expression of its intronless version integrated on the chromosome, was sufficient to suppress the cold-sensitive phenotype, but did not affect splicing efficiency (data not shown). Rather, splicing of the PCC1 intron was strongly and specifically affected by the U1-5A mutation, presumably due to the destabilizing effect of an A-A mismatch present in the duplex between U1-5A snRNA and the 5′ splice site of the PCC1 intron (data not shown). This indicates that splicing of the PCC1 intron is the main limiting factor for growth in the U1-5A strain. Pcc1p is required for normal cell cycle progression and mating projection formation PCC1 is not essential, but pcc1 null cells grow very slowly at all temperatures and are thermosensitive at 34°C (data not shown). We thus constructed a thermosensitive mutant allele, pcc1-4, that we integrated at the PCC1 genomic locus to facilitate phenotypic analyses. Visualization of DAPI stained pcc1-4 cells after a shift to the nonpermissive temperature (37°C) showed a marked increase in the fraction of unbudded cells with a single nucleus compared to the WT (Supplementary Figure S1) and a concomitant decrease in the fraction of small to medium budded cells (S-G2) and anaphase cells. These results show that pcc1-4 cells are defective for bud formation at the nonpermissive temperature. In contrast, the fraction of large-budded cells with two separated nuclei was not significantly reduced compared to the WT, suggesting the existence of an additional defect in exit from mitosis or cytokinesis. Microtubule staining of pcc1-4 cells at the nonpermissive temperature with GFP-Tub1 indicated that the mitotic spindle had disassembled in these cells, suggesting that they had undergone mitosis and were delayed for cytokinesis/cell separation (data not shown). A parallel FACS analysis of pcc1-4 cells at the nonpermissive temperature (Supplementary Figure S1B) indicated an increase in the population of cells with a 1C DNA content, most likely representing unbudded cells, and a decrease in S-phase cells. Consistent with cytological observations, we did not observe complete disappearance of the population with a 2C DNA content. The existence of two defects at the G1/S and M/G1 transitions was confirmed by FACS analysis of alpha factor and nocodazole-synchronized cells and colony-forming assays indicated that pcc1-4 cells maintained high viability after 8 h of incubation at the restrictive temperature (data not shown). Treating MATa cells with alpha pheromone blocks cells in the G1 phase and induces mating projections. Remarkably, pheromone-treated pcc1-4 cells accumulated largely as unbudded cells without mating projections at the nonpermissive temperature (Supplementary Figure S1C). Unbudded pcc1-4 cells at 37°C accumulated faster in the presence compared to the absence of alpha factor (data not shown), indicating that pcc1-4 cells arrest division in response to pheromone, but they are defective in pheromone-induced morphogenesis. Pcc1p is required for normal gene expression To gain mechanistic insight into the function of Pcc1p, we first analyzed its role in the mating pheromone response that is characterized by the activation of a complex transcriptional program. We analyzed by real time RT–PCR the expression of a set of genes induced by alpha factor to assess the integrity of the transcriptional response in pcc1-4 cells. FUS1, FAR1 and STE2 are strongly induced after alpha-factor exposure. As shown in Figure 1
To monitor transcriptional activity more directly, we analyzed RNAPII occupancy in the pcc1-4 mutant at the nonpermissive temperature by chromatin immunoprecipitation (ChIP) experiments. Mutation of Pcc1p significantly affects RNAPII density on STE2, FUS1 and GAL1 genes, and the lower levels of RNAPII were evenly distributed along the ORFs (Figure 2A
Formation of the transcription PIC requires the association of specific activators with upstream activating sequences (UAS), which promote the interaction of co-activators and TBP (Spt15p) with the nearby promoters. Activation of galactose-inducible genes requires the sequential recruitment of the SAGA and Mediator co-activators by the DNA-bound Gal4p activator (Bryant and Ptashne, 2003; Bhaumik et al, 2004). To identify the step of transcription that is affected by mutation of Pcc1p, we analyzed the recruitment of Gal4p activator as well as SAGA and Mediator components (respectively Gcn5p and Rgr1p) and TBP (Spt15p) to the GAL1 gene in a pcc1-4 genetic background. As shown in Figure 2B We also analyzed the recruitment of the Ste12p activator to the promoter of the FAR1 gene, whose transcription is sensitive to Pcc1p (Supplementary Figure S2B). In contrast to the Gal4p activator, binding of Ste12p has been shown to increase upon activation of transcription (Ren et al, 2000). In both wild type and pcc1-4 cells at the nonpermissive temperature, binding of Ste12p was increased by a very similar factor upon pheromone exposure, further confirming that mutation of Pcc1p does not affect signaling or activator binding. Together, these results indicate that Pcc1p is required for the efficient transcription of genes induced by alpha factor and galactose. Pcc1p function is dispensable for the binding of the Gal4p and Ste12p activators, but is necessary for the efficient recruitment of TBP and the SAGA and Mediator co-activators at the GAL1 promoter. These results indicate that pcc1 mutants are affected at an early step of transcription activation that precedes TBP recruitment and PIC assembly. Finally, they also strongly suggest that the polarized growth defects observed in pcc1 mutants are due to an impairment of the transcriptional response. Pcc1p associates with the chromatin of RNAPII transcribed genes To rule out possible indirect effects, we asked whether Pcc1p is recruited to the DNA of its target genes, and whether recruitment occurs in a transcription-dependent manner. To this end, we performed ChIP analysis with yeast cells expressing a TAP-tagged form of Pcc1p. Pcc1-TAP is functional, as this strain was only slightly affected for growth at 37°C. MAT a cells were grown at 30° and aliquots were taken before and after (5 and 15 min) alpha factor addition. Real-time PCR analysis of DNA co-immunoprecipitated with Pcc1-TAP indicates that it associates strongly with STE2, FUS1, FAR1 and FUS3 genes upon transcriptional induction (Figure 3A
Taken together, these data indicate that Pcc1p is recruited to several independently regulated genes (alpha-factor, galactose- and stress-induced genes) in a transcription-dependent manner. PCC1 interacts genetically with genes encoding components of the transcription machinery and chromatin modifying enzyme To further test the implication of Pcc1p in transcription, we sought genetic interactions between pcc1-4 and mutants of the transcription apparatus. Mutation of Pcc1p severely affected growth when associated with mutants of RNAPII holoenzyme components such as Rpb1p, Rpb4p and Rpb9p (Supplementary Figure S4). In the latter case, the genetic interaction is particularly strong as the pcc1-4 rpb9Δ double mutant is inviable at 34°C while the two single mutants grow reasonably well at this temperature. The pcc1-4 mutation also severely affected growth when combined with rad3-6.4, a transcription-defective allele of RAD3 (Jensen et al, 2001, 2004) that is a component of the GTF TFIIH. Efficient transcription in the context of a chromatin template requires the recruitment to promoters of co-activators that possess chromatin-modifying activities. The SAGA and NuA4 complexes are transcriptional co-activators endowed with histone acetylase activity borne, respectively, by the Gcn5p and Esa1p subunits. Double mutants pcc1-4 gcn5Δ and pcc1-4 esa1-1851 (as ESA1 is essential, we used a thermosensitive allele in this case) were strongly affected in growth compared to single mutants, further underscoring the relationships between Pcc1p and efficient transcription. This is also consistent with the finding (reported above) that Pcc1p integrity is required for efficient Gcn5p recruitment and suggests that Pcc1p might collaborate with additional co-activators (i.e. NuA4) in the regulation of gene expression. The histone deacetylase Rpd3p has been shown to affect gene expression both positively and negatively (Kadosh and Struhl, 1998; Bernstein et al, 2000; Kurdistani et al, 2002; Robyr et al, 2002; De Nadal et al, 2004; Carrozza et al, 2005). Deletion of RPD3 in a pcc1-4 context led to a strong synthetic growth phenotype (Supplementary Figure S4). We also constructed a pcc1-4 sin3Δ double mutant, as Sin3p is part of the histone deacetylase B (HDB) complex that contains Rpd3p and is required for its activity (Kadosh and Struhl, 1997; Kasten et al, 1997). pcc1-4 sin3Δ cells grew poorly (data not shown), which confirms the requirement for Rpd3p deacetylase when Pcc1p function is impaired. Finally, deletion of HDA1, encoding the catalytic component of the histone deacetylase A (HDA) (Robyr et al, 2002), or deletion of HOS2, belonging to the same class of HDAC as Rpd3p, did not affect growth of a pcc1-4 mutant (data not shown). Together these results underscore a role for Pcc1p in transcription, and might suggest a function related to chromatin remodeling/modifying. Isolation and characterization of the Pcc1p-containing complex To identify proteins interacting with Pcc1p, we purified TAP-tagged Pcc1p (Rigaut et al, 1999) and analyzed the associated complex by mass spectrometry (data not shown). In addition to Pcc1p, the purified complex contained Kae1p, Bud32p and a small protein encoded by ORF YJL184w that was assigned the temporary designation Gon7p and which we propose to name Pcc2p. TAP-tag purification of the Pcc2p-associated complex followed by mass spectrometric peptide analysis confirmed the co-purification of these four proteins (Figure 4A
Interaction of Kae1p, Bud32p, Gon7p and Cgi121p was also reported in a large-scale analysis of yeast complexes (Ho et al, 2002; Gavin et al, 2006). The Bud32p–Kae1p, Pcc1p–Pcc2p, and Pcc1p–Kae1p interactions were also observed by two-hybrid analysis (our unpublished results; Lopreiato et al, 2004). Pcc2p appears to have orthologues only in fungi and no known functional domains were found in its sequence. Kae1p, on the other hand, is universally conserved and is similar in sequence to a family of zinc-dependent endoproteases (Mellors and Lo, 1995; Lopreiato et al, 2004). Finally, Bud32p is a serine/threonine kinase homologous to human PRPK, a factor that has been shown to bind and phosphorylate p53 (Abe et al, 2001; Facchin et al, 2003). We named this complex the EKC to reflect these characteristic features and its association with transcribed chromatin (see above), Although KAE1 and PCC2 are strictly nonessential, pcc2Δ and kae1Δ cells grow poorly at all temperatures (data not shown). Therefore, we generated temperature sensitive mutants of both genes and integrated them at their respective genomic loci. These mutants have a cell cycle phenotype that is similar to that of pcc1 cells (data not shown) and were inviable when combined with the pcc1-4 allele, suggesting that either mutant alone partially compromises the function of the EKC complex and that the latter is required for cell viability (Supplementary Figure S5). Pcc2p/Gon7p and Kae1p are nuclear (data not shown) and can be crosslinked to the DNA of alpha factor induced genes and GAL1 (Supplementary Figure S5 and data not shown), suggesting that the whole complex is recruited to genes during transcription. Together, these data strongly suggest that the EKC complex is a functional unit. Conservation of the EKC complex Comparison of the Pcc1p protein sequence with several databases revealed that this gene belongs to a very large family of proteins conserved from archaebacteria to man (Supplementary Figure S6). Three genes coding for putative homologous proteins are present in the human genome. CTAG1/NY-ESO1 and CTAG2/NY-ESO2 belong to the family of cancer-testis antigens and are specifically expressed in several human tumors of different origin and in normal testes and ovaries (Chen et al, 1997, 1998; Jager et al, 1998; Stockert et al, 1998). A third gene, ESO3, codes for a protein that is ubiquitously expressed (Faranda et al, 1996; Alpen et al, 2002) and is similar to NY-ESO1 and NY-ESO2. Expression of ESO3 in yeast did not restore normal growth to a pcc1 null strain (data not shown). However, sequence comparison of the PCC1 family allowed the identification of two conserved domains of unknown function that we named Pcc1 Homology Box 1 (PHB1) and 2 (PHB2) (Supplementary Figure S6). Within PHB1 8 residues were almost universally conserved among the different family members. Deletion of PHB1 or mutation of its highly conserved residues led to inactivation of the protein, indicating that this region is required for Pcc1p function or stability (Supplementary Figure S6). Interestingly, replacing the N-terminal domain with the corresponding regions from the human CTAG1/NY-ESO1 or ESO3 sequences partially restored Pcc1p function (Supplementary Figure S6), which suggests that the Pcc1p gene and its human homologues share at least some functions. Kae1p is also extremely well conserved in archae and eukaryotes (Figure 5A
The zinc-binding motif of Kae1p is required for viability Sequence similarities indicate that Kae1p is a putative endopeptidase of the M22 family of metalloproteases (Mellors and Lo, 1995; Lopreiato et al, 2004). Similar enzymes are also present in bacteria, and an enzymatic activity has been experimentally demonstrated for the Pasteurella haemolytica enzymes (Abdullah et al, 1991). The catalytically essential residues of these proteins have not been identified, but the putative zinc-binding domain is highly conserved from bacteria to man (Figure 5A Discussion The EKC complex is involved in transcription In this paper, we report the first characterization of a novel and highly conserved complex of proteins with a crucial role in transcription. pcc1 mutant cells are defective for normal cell cycle progression and are unable to fully respond to pheromone. We show that transcriptional defects are likely to be responsible for these phenotypes. The response to pheromone involves the transcriptional induction of genes required for mating behavior, including cell cycle arrest and the formation of mating projections. We found that transcripts derived from several pheromone-inducible genes, such as FUS1, STE2 and FAR1 are significantly decreased in pcc1 mutant cells upon the shift to the nonpermissive temperature, which was paralleled by the decreased RNAPII and TBP occupancy at the genomic loci, indicating the transcriptional nature of the defect. Finally, the implication of Pcc1p (and presumably the whole EKC complex) in transcription is likely to be direct, as we demonstrated by ChIP experiments showing that Pcc1p, Kae1p and Pcc2p (this report) and Bud32p (Lopreiato et al, in preparation) are recruited to several genomic loci upon transcriptional induction. The ChIP signal we observed for Pcc1-TAP at GAL1 was comparable to the signal observed for components of the transcriptional co-activators SAGA and Mediator. This notion is also strongly supported by genetic interactions between pcc1-4 and several mutants of the transcriptional and chromatin-modifying machinery. The transcriptional role of the EKC complex is not restricted to pheromone-inducible genes, but also extends to the galactose-inducible GAL1 gene. Preliminary DNA microarray experiments also identified a set of genes that are affected in the pcc1-4 mutant at the nonpermissive temperature. Among these we found, as expected, several pheromone-inducible genes (FUS1, FUS3, BAR1), but also genes required for cytokinesis (SCW1, CWP1, HOF1, CTS1 and EGT2), and polarized cell growth (CLN2, encoding a G1 cyclin), which might explain at least part of the phenotypes observed in pcc1-4 cells. The EKC complex is required for efficient recruitment of transcriptional co-activators ChIP analyses indicate that Pcc1p is required for efficient recruitment of SAGA and Mediator co-activators (or at least their Gcn5p and Rgr1p components) to the promoter of the GAL1 gene. As defective recruitment of these complexes affects TBP (Spt15p) and RNAPII recruitment (which we observe), it is likely that a transcriptional defect in pcc1-4 cells lies upstream of PIC formation and downstream of Gal4p binding at the level of SAGA recruitment to the GAL1 promoter and/or the stabilization of this interaction, which is known to precede binding of the Mediator (Bryant and Ptashne, 2003; Bhaumik et al, 2004). Although we have not detected Gal4p or SAGA or Mediator components in EKC preparations by mass spectrometry, it is possible that these interactions are transient and do not survive the purification procedure. Consistent with this notion, Gal4p, the SAGA component Taf6p, and the Mediator component Med7p were isolated in the same large-scale two-hybrid screen that also identified Pcc2p and Kae1p as prey using Pcc1p as a bait (our unpublished data). It is possible that these interactions contribute to the overall network of interactions that recruits and/or stabilizes the factors required for PIC formation. Recent work from the Tansey and Workman laboratories (Lee et al, 2005) has unveiled a role for the 19S proteasome regulatory particle in promoting the interaction of the SAGA co-activator with transcriptional activators, perhaps by remodeling the SAGA complex. Interestingly, in a large-scale study of yeast protein complexes (Ho et al, 2002), Bud32p and Kae1p were found to coprecipitate with five subunits (Rpt1p, Rpt3p and Rpn1p, Rpn5p and Rpn6p) of the 19S regulatory component of the proteasome. This physical interaction between members of the EKC complex and the 19S proteasome, and the observation that both promote SAGA interaction with the GAL genes, further underscore a direct role for the EKC in transcription and might underlie a common mechanism of action. A role in transcriptional activation for the EKC is generally consistent with the genetic interactions we observed. The strong genetic interaction observed between PCC1 and the NuA4 histone acetylase ESA1 might indicate that Pcc1p (and the EKC complex) are also required for efficient recruitment of NuA4, and possibly of other co-activators, to their target genes. A strong genetic interaction was also found with the RPD3 HDAC. Although HDACs are generally associated with repression of gene expression, a direct role for Rpd3p in the activation of several stress-induced genes was recently described (De Nadal et al, 2004), suggesting the possible existence of common targets with the EKC complex. Whether the genetic interactions with histone acetylases/deacetylases imply a synergistic relationship in gene activation through a chromatin-modifying function is a matter for further investigations. The transcription-dependent distribution of Pcc1p as measured by ChIP is not restricted to the promoter regions of the genes tested. The reason for this is presently unclear, although it is not uncommon that the distribution of ChIP signals for several transcription or nontranscription factors do not reflect the main (or the most visible) role of the factor. As for the 19S particle of the proteasome (Ferdous et al, 2001; Gonzalez et al, 2002; Gillette et al, 2004), it is possible that the distribution of the EKC complex reflects an additional and overlapping role in transcription elongation and/or termination. The components and conservation of the EKC complex The EKC complex contains, beside Pcc1p, four additional proteins: Kae1p, Gon7p/Pcc2p, Bud32p and Cgi121. With the exception of Pcc1p these proteins were also found to interact in a recent large-scale analysis (Gavin et al, 2006) of protein complexes. We extend here these results and prove by gel filtration analysis that they define a single complex an apparent molecular mass of 300 kDa. Preliminary cryo-EM images of the complex (data not shown) suggest an elongated form, which might explain the discrepancy between the expected and the apparent molecular mass. The physical interaction of these proteins, their genetic interactions and the similar phenotype of thermosensitive mutants indicate that the EKC complex is a functional unit. Kae1p, Pcc1p and Bud32p are universally conserved from archaebacteria to man, with a strikingly high level of identity (roughly 60%) between the human homologue of Kae1p (OSGEP) and the yeast protein. Interestingly, the Bud32p and Kae1p homologues in archae are fused in the same polypeptide (Lopreiato et al, 2004). Based on the functional complementation data reported here and in another report for PRPK, the human homologue of Bud32p (Facchin et al, 2003), it is likely that a related complex exists in most or all eukaryotes and archae with a similar transcription-related function. Consistent with this notion, it was shown that PRPK is able to bind and phosphorylate p53, thus activating p53-dependent transcription (Abe et al, 2001; Facchin et al, 2003). It is tempting to speculate that the function of the CTAG1 and/or CTAG2 cancer-testis antigens (Chen et al, 1998) is also linked to the transcription process and that their derepression in tumors may be causally related to oncogenesis. What is the mechanism of action of the EKC complex? One of the most interesting features of the EKC complex is a putative Zn-binding endopeptidase activity associated with the Kae1 subunit. Although proteolytic activity has not been directly demonstrated for Kae1p, we showed that its putative zinc-binding domain, which is conserved in the bacterial proteases, is required for its function in vivo. A role for a proteolytic activity in transcription regulation is not unprecedented. The proteolytic activity of the 26S proteasome is required for its role in transcription termination, although the targets remain elusive (Gillette et al, 2004). Similarly, degradation of a transcriptionally engaged form of Gal4p was recently shown to be required for the production of translatable RNAs (Muratani et al, 2005). Thus, the EKC complex might impact transcription through its proteolytic activity, although the targets and mechanism of action remain to be identified. Sequence similarity searches have also revealed the presence of an Hsp70 fold in the Kae1p family, leading to the suggestion that this protein is an ATP-dependent protease with chaperone-like activity (Aravind and Koonin, 1999). It is thus possible that a chaperone activity is responsible for the transcriptional role of Kae1p independently of its (putative) endopeptidase function. In this perspective, the EKC complex might impact transcription through an ATPase function in a way that would be analogous to that proposed for the 19S particle of the proteasome (Ferdous et al, 2001; Ezhkova and Tansey, 2004; Lee et al, 2005). While this work was in progress, Downey et al (2006) identified subunits of the EKC complex, which they named KEOPS, as being involved in telomere maintenance. The authors provide evidence that the Bud32p and Cgi121p proteins are required for telomere uncapping and single-strand DNA accumulation in a cdc13-1 capping mutant. Deletion of BUD32 is also shown to affect de novo synthesis of telomeres, but neither telomerase recruitment nor its activity in an in vitro assay. The authors suggest that Bud32p (and presumably the KEOPS complex) promotes accessibility to the chromosome 3′ end, which could explain the seemingly antithetical effects of being required both for telomere synthesis and telomere degradation in a capping mutant. At this stage, it is unclear whether two distinct functions exist for the EKC/KEOPS complex or whether there is only one primary function that affects both transcription and telomere length. We note that the essential function of the EKC/KEOPS cannot be the maintenance of telomere length and/or the positive regulation of telomerase function as thermosensitive mutants of Pcc1p, Gon7p/Pcc2p and Kae1p stop dividing at the nonpermissive temperature after a few divisions, while loss of telomerase leads to replicative senescence only after 60–80 doublings (Lundblad and Szostak, 1989). Two recent genome-wide studies (Askree et al, 2004; Gatbonton et al, 2006) have reported that telomere length is controlled by a large number of genes (estimated at 3% of the yeast genome), the largest fraction of which codes for factors involved in transcription and RNA metabolism (Askree et al, 2004; Gatbonton et al, 2006). Thus, it cannot be excluded that some unknown consequences of perturbing transcription (or RNA processing/turnover) affects telomere maintenance. However, we favor the hypothesis that the primary role of Bud32p and the EKC/KEOPS complex relates to the establishment and the maintenance of the structure of chromatin, possibly through an ATP-dependent remodeling function borne by Kae1p. Such a function would be required at telomeres as well as elsewhere in the genome, thus affecting chromosome 3′-end accessibility and transcription. The characterization of the EKC/KEOPS complex by Downey et al (2006), and in this study opens up the exciting perspective of defining the targets and mode of action of a potentially new mechanism to control the expression and the integrity of the genome. Materials and methods Standard methods for construction and manipulation of yeast strains are described in Supplementary methods RNA and ChIP analysis RNAs were prepared and analyzed by real-time RT–PCR (LightCycler, Roche as previously described (Libri et al, 2002; Jensen et al, 2004)). Primers used are listed in Supplementary Table S2. Amplification efficiencies were calculated from serial dilutions for every set of amplification reactions. RNA levels were normalized to the levels of U4 snRNA. As reactions for U4 snRNA have to be diluted to maintain linearity, the ratios are expressed in arbitrary units. Preparations of chromatin were performed essentially as described (Jensen et al, 2004). Immunoprecipitations of 500 μl fractions were performed with saturating amounts of anti-Rpb3p (Neoclone), anti-Gal4 (Santa Cruz Biotech.), anti-myc (9E10, Santa Cruz Biotech.), anti-HA (F-7, Santa Cruz Biotech.) antibodies or with 25 μl of IgG-Sepharose (Amersham). Immunoprecipitated DNA was quantified by real-time PCR (LightCycler), normalized to a dilution of input DNA and expressed as arbitrary units. Amplification efficiencies for every set of primers (Supplementary Table S2) was measured as described above. Protein purification and identification TAP tag purifications of the EKC complex were performed from a yeast whole-cell extract (12 l, OD600 of 1.0–1.5), essentially as described (Rigaut et al, 1999). Gel filtration analysis was performed on a Superdex 200 (10/300 mm) column with whole-cell extracts or after the first purification step of the TAP-tag procedure. Proteins were identified by peptide mass fingerprinting with a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) Voyager DE-STR mass spectrometer (Applied Biosystems, Framingham, MA, USA). The Investigator Progest system (Genomic Solutions) was used for in-gel digestion of specific protein bands with modified porcine trypsin (Promega), and the Investigator ProMS system (Genomic Solutions) was used for purification with Zip-Tip C18 (Millipore) and for loading the sample with the matrix (alpha-Cyano 4-Hydroxy Cinnamic Acid) on the Maldi sample plate. Monoisotopic masses were assigned using a local copy of the MS-Fit3.2 portion of the Protein Prospector package (University of California, Mass Spectrometry Facility, San Francisco, USA) to search the yeast ORF database. The parameters were set as follows: no restriction on the isoelectric point of proteins. In total, 50 p.p.m. were allowed as the maximum mass error, and one incomplete cleavage per peptide was considered. Proteins present within the gel-filtered complexes were identified by a combined analysis using MS and MS/MS data (4800 MALDI TOF/TOF Analyser, Applied Biosystems, MDS.SCIEX). The number of precursor peaks for MS/MS acquisition per band and S/N filter were set at 10 and 20 respectively. For searching the yeast ORF database, a local copy of Mascot (Matrix Science, London, UK) was used with a mass tolerance of 50 p.p.m. for MS and 0.3 Da for MS/MS. The database search criterions were based on individual protein ion score (based on MS and MS/MS) and individual ion score (based on MS/MS) 95% confidence interval (P<0.05) for unknown proteins searched against yeast ORF database.Supplementary Figure S1 Click here to view.(1.9M, eps) Supplementary Figure S2 Click here to view.(1.3M, pdf) Supplementary Figure S3 Click here to view.(36K, eps) Supplementary Figure S4 Click here to view.(9.2M, eps) Supplementary Figure S5 Click here to view.(2.7M, eps) Supplementary Figure S6 Click here to view.(234K, tiff) Supplementary Table S1 Click here to view.(38K, doc) Supplementary Table S2 Click here to view.(28K, doc) Legends to Supplementary Figures and Tables Click here to view.(25K, doc) Supplementary Methods Click here to view.(52K, doc) Acknowledgments We thank L Kuras and C Saveanu for critical reading of the manuscript; F Lacroute, C Saguez and B Seraphin for gift of strains; F Wyers for help with the TAP-tagging procedure; A Dziembowski for help with gel filtration procedures and J Boulay for expert technical assistance. This work was supported by the CNRS, the Ligue contre le Cancer and Pasteur Génopole-IDF. EKR and RL have been recipients of fellowships from the Association pour la Recherche sur le Cancer (ARC). RL wishes to dedicate this paper to the memory of his late father Pietro. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Mol Biol Cell. 1998 Dec; 9(12):3273-97.
[Mol Biol Cell. 1998]Genes Dev. 2002 Dec 1; 16(23):3017-33.
[Genes Dev. 2002]Mol Cell Biol. 1988 Jun; 8(6):2484-93.
[Mol Cell Biol. 1988]Genetics. 1990 Jan; 124(1):81-90.
[Genetics. 1990]Mol Gen Genet. 1993 Nov; 241(3-4):327-34.
[Mol Gen Genet. 1993]Nature. 2000 Jan 6; 403(6765):41-5.
[Nature. 2000]Science. 2001 Aug 10; 293(5532):1074-80.
[Science. 2001]Science. 2002 Nov 15; 298(5597):1412-4.
[Science. 2002]Nature. 2004 Jan 22; 427(6972):370-4.
[Nature. 2004]Nat Rev Mol Cell Biol. 2003 Mar; 4(3):192-201.
[Nat Rev Mol Cell Biol. 2003]EMBO J. 1988 Aug; 7(8):2533-8.
[EMBO J. 1988]Genome Biol. 2003; 4(7):R45.
[Genome Biol. 2003]Mol Cell. 2003 May; 11(5):1301-9.
[Mol Cell. 2003]Genes Dev. 2004 Feb 1; 18(3):333-43.
[Genes Dev. 2004]Science. 2000 Dec 22; 290(5500):2306-9.
[Science. 2000]Mol Cell. 2004 Oct 22; 16(2):235-44.
[Mol Cell. 2004]Curr Biol. 2001 Oct 30; 11(21):1711-5.
[Curr Biol. 2001]Genes Dev. 1998 Mar 15; 12(6):797-805.
[Genes Dev. 1998]Proc Natl Acad Sci U S A. 2000 Dec 5; 97(25):13708-13.
[Proc Natl Acad Sci U S A. 2000]Nat Genet. 2002 Jul; 31(3):248-54.
[Nat Genet. 2002]Cell. 2002 May 17; 109(4):437-46.
[Cell. 2002]Nature. 2004 Jan 22; 427(6972):370-4.
[Nature. 2004]Nat Biotechnol. 1999 Oct; 17(10):1030-2.
[Nat Biotechnol. 1999]Nature. 2002 Jan 10; 415(6868):180-3.
[Nature. 2002]Nature. 2006 Mar 30; 440(7084):631-6.
[Nature. 2006]Biochem J. 2004 Jan 15; 377(Pt 2):395-405.
[Biochem J. 2004]Methods Enzymol. 1995; 248():728-40.
[Methods Enzymol. 1995]J Biol Chem. 2001 Nov 23; 276(47):44003-11.
[J Biol Chem. 2001]Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):6919-23.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1997 Mar 4; 94(5):1914-8.
[Proc Natl Acad Sci U S A. 1997]J Exp Med. 1998 Jan 19; 187(2):265-70.
[J Exp Med. 1998]J Exp Med. 1998 Apr 20; 187(8):1349-54.
[J Exp Med. 1998]Genomics. 1996 Jun 15; 34(3):323-7.
[Genomics. 1996]Biochem J. 2004 Jan 15; 377(Pt 2):395-405.
[Biochem J. 2004]FEBS Lett. 2003 Aug 14; 549(1-3):63-6.
[FEBS Lett. 2003]Methods Enzymol. 1995; 248():728-40.
[Methods Enzymol. 1995]Biochem J. 2004 Jan 15; 377(Pt 2):395-405.
[Biochem J. 2004]J Bacteriol. 1991 Sep; 173(18):5597-603.
[J Bacteriol. 1991]Mol Cell. 2003 May; 11(5):1301-9.
[Mol Cell. 2003]Genes Dev. 2004 Feb 1; 18(3):333-43.
[Genes Dev. 2004]Cell. 2005 Nov 4; 123(3):423-36.
[Cell. 2005]Nature. 2002 Jan 10; 415(6868):180-3.
[Nature. 2002]Nature. 2004 Jan 22; 427(6972):370-4.
[Nature. 2004]Mol Cell. 2001 May; 7(5):981-91.
[Mol Cell. 2001]Science. 2002 Apr 19; 296(5567):548-50.
[Science. 2002]Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):5904-9.
[Proc Natl Acad Sci U S A. 2004]Nature. 2006 Mar 30; 440(7084):631-6.
[Nature. 2006]Biochem J. 2004 Jan 15; 377(Pt 2):395-405.
[Biochem J. 2004]FEBS Lett. 2003 Aug 14; 549(1-3):63-6.
[FEBS Lett. 2003]J Biol Chem. 2001 Nov 23; 276(47):44003-11.
[J Biol Chem. 2001]Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):6919-23.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):5904-9.
[Proc Natl Acad Sci U S A. 2004]Cell. 2005 Mar 25; 120(6):887-99.
[Cell. 2005]J Mol Biol. 1999 Apr 16; 287(5):1023-40.
[J Mol Biol. 1999]Mol Cell. 2001 May; 7(5):981-91.
[Mol Cell. 2001]Mol Cell. 2004 Feb 13; 13(3):435-42.
[Mol Cell. 2004]Cell. 2006 Mar 24; 124(6):1155-68.
[Cell. 2006]Cell. 1989 May 19; 57(4):633-43.
[Cell. 1989]Proc Natl Acad Sci U S A. 2004 Jun 8; 101(23):8658-63.
[Proc Natl Acad Sci U S A. 2004]PLoS Genet. 2006 Mar; 2(3):e35.
[PLoS Genet. 2006]Cell. 2006 Mar 24; 124(6):1155-68.
[Cell. 2006]Mol Cell Biol. 2002 Dec; 22(23):8254-66.
[Mol Cell Biol. 2002]Mol Cell. 2004 Oct 22; 16(2):235-44.
[Mol Cell. 2004]Mol Cell. 2004 Oct 22; 16(2):235-44.
[Mol Cell. 2004]Nat Biotechnol. 1999 Oct; 17(10):1030-2.
[Nat Biotechnol. 1999]